R.D. Lawrence Lecture 1995 Mrs Sprat's Diabetes: Some metabolic insights

Diabetic Medicine

Volumn 13, Issue 7, 1996, Pages 616-624

  Coppack, Simon W ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus; Metabolism; Obesity

Indexed keywords

DIABETES MELLITUS; METABOLISM; OBESITY; REVIEW;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPOPROTEIN LIPASE; OBESITY;

EID: 0030036383     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199607)13:7<616::AID-DIA124>3.0.CO;2-1     Document Type: Review

References (87)

1. Lawrence RD. The Diabetic Life, 13th edn. Butterworth: London, 1952 .
2. Lawrence RD. Interactions of fat and carbohydrate metabolism - new aspects and therapies. Proc R Soc Med 1941; 35: 1-10.
3. Lawrence RD. Three types of human diabetes. Ann Intern Med 1955; 43: 1199-1209.
4. Lawrence RD. Diabetes: with special reference to high carbohydrate diets. Br Med J 1933; 16 Sep: 1-13.
5. Jenkins DJA, Hockaday TDR, Wolever TMS, et al. Dietary fibre and ketone bodies; reduced urinary 3-hydroxybutyrate excretion in diabetes of guar. Br Med J 1979; 1555.
6. Department of Health. The Health of the Nation: a Strategy for Health in England. London: HMSO, 1992.
7. Kuszmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 1992; 55: 495S-502S.
8. Sørensen TIA, Price RA. Secular trends in body mass index among Danish young men. Int J Obes Rel Metab Dis 1990; 14: 411-419.
9. Bennett N, Dodd T, Flatley J, Freeth S, Bolling K. Health Survey for England 1993. London: HMSO, 1995.
10. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? Br Med J 1995; 311: 437-439.
11. National Food Survey Committee and Ministry of Agriculture Fisheries and Foods. Household Food Consumption and Expenditure. Annual Report of the National Food Survey Committee. London: HMSO, 1994.
12. Tucker LA, Kano MJ. Dietary fat and body fat: a multivariate study of 205 adult females. Am J Clin Nutr 1992; 56: 616-622.
13. Klesges RC, Klesges LM, Haddock CK, Eck LH. A longitudinal analysis of the impact of dietary intake and physical activity on weight change in adults. Am J Clin Nutr 1992; 55: 818-822.
14. Jeffery RW, Hellerstedt WL, French SA, Baxter JE. A randomized trial of counseling for fat restriction versus calorie restriction in the treatment of obesity. Int J Obes Rel Metab Dis 1995; 19: 132-137.
15. Flatt JP. Importance of nutrient balance in body weight regulation. Diabetes Metab Rev 1988; 4: 571-581.
16. West D, Boozer CN, Moody DL, Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992; 262: E1025-E1032.
17. Vogler GP, Sorensen TIA, Stunkard AJ, Srinivasan MR, Rao DC. Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int J Obes Rel Metab Dis 1995; 19: 40-45.
18. Eaton SB. Humans, lipids and evolution. Lipids 1992; 27: 814-820.
19. Lissner L, Heitmann BL. The dietary fat : carbohydrate ratio in relation to body weight. Curr Opin Lipidol 1995; 6: 8-13.
20. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
21. Halaas JL, Cajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
22. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
23. Garrow JS, Webster JD. Effects on weight and metabolic rate of obese women of a 3.4 MJ (800 kcal) diet. Lancet 1989; 1: 1429-1431.
24. Halverson JD, Kramer J, Cave A, Permutt A, Santiago J. Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery 1982; 92: 235-240.
25. Olefsky J, Crapo PA, Ginsberg H, Reaven GM. Metabolic effects of increased caloric intake in man. Metabolism 1975; 24: 495-503.
26. Metropolitan Life Assurance Company. Net weight standard for men and women. Stat Bull Metrol Life Found 1959; 40: 1-4.
27. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change and coronary heart disease in women: risk within the 'normal' weight range. J Am Med Assoc 1995; 273: 461-465.
28. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
29. Fontbonne A, Thibult N, Eschwège E, Ducimetière P. Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, a 15 year followup. Diabetologia 1992; 35: 464-468.
30. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-513.
31. Frayn KN, Coppack SW. Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 1992; 82: 1-8.
32. Lissner L, Sjöström L, Bengtsson C, Bouchard C, Larsson B. The natural history of obesity in an obese population and associations with metabolic aberrations. Int J Obes Rel Metab Dis 1994; 18: 441-447.
33. Golay A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab 1986; 63: 481-484.
34. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states: relationship to atherogenesis. Diabetes Care 1991; 14: 839-855.
35. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991; 11: 2-14.
36. Assmann G, Schulte H. Identification of individuals at high risk for myocardial infarction. Atherosclerosis 1994; 110 (suppl): S11-S21.
37. Austin MA, Hokanson JE. Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease. Med Clin North Am 1994; 78: 99-115.
38. Stewart MW, Laker MF, Alberti KGMM. The contribution of lipids to coronary heart disease in diabetes mellitus. J Intern Med Suppl 1994; 736: 41-46.
39. Hodis HN, Mack WJ. Triglyceride-rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol 1995; 6: 209-214.
40. Opie LH, Walfish PG. Plasma free fatty acid concentration in obesity. N Engl J Med 1963; 268: 757-760.
41. Coppack SW, Jensen MD, Miles JM. The in vivo regulation of lipolysis in humans. J Lipid Res 1994; 35: 177-193.
42. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785-789.
43. Astrup A, Buemann B, Western P, Toubro S, Raben A, Christensen NJ. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 1994; 59: 350-355.
44. Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 1976; 12: 563-571.
45. 14-labelled unesterified fatty acids in normal human subjects. J Clin Invest 1958; 37: 1504-1515.
46. Miles JM, Jensen MD. Determination of plasma-free fatty acid kinetics with tracers: methodological considerations. J Parenter Enterai Nutr 1991; 15 (suppl): 90S-92S.
47. Björntorp P, Bergman H, Varnauskas E. Plasma free fatty acid turnover in obesity. Acta Med Scand 1969; 185: 351-356.
48. Del Prato S, Enzi G, Vigili de Kreutzenberg S, et al. Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia 1990; 33: 228-236.
49. Howard BV, Klimes I, Vasquez B, Brady D, Nagulesparan M, Unger RH. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. J Clin Endocrinol Metab 1984; 58: 544-548.
50. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of tree fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72: 96-107.
51. Renold AE, Cahill GF. Metabolism of isolated adipose tissue: A summary. In: Renold AE, Cahill GF, eds. Handbook of Physiology, section 5. Adipose Tissue. Washington D.C.: American Physiological Society, 1965; 483-490.
52. Rebuffé-Scrive M, Lönnroth P, Marin P, Wesslau C, Björntorp P, Smith U. Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes Rel Metab Dis 1987; 11: 347-355.
53. Edens NK, Leibel RL, Hirsch J. Mechanism of free fatty acid re-esterification in human adipocytes in vitro. J Lipid Res 1990; 31: 1423-1431.
54. Lillioja S, Foley JE, Bogardus C, Mott DM, Howard BV. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons. Metabolism 1986; 35: 505-514.
55. Arner P, Bolinder J, Eliasson A, Lundin A, Ungerstedt U. Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am J Physiol 1988; 255: E737-E742.
56. Lönnroth P, Jansson P-AE, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228-E231.
57. Frayn KN, Coppack SW, Humphreys SM, Whyte PL. Metabolic characteristics of human adipose tissue in vivo. Clin Sci 1989; 76: 509-516.
58. Simonsen L, Bülow J, Madsen J. Adipose tissue metabolism in humans determined by vein catheterization and microdialysis techniques. Am J Physiol 1994; 266: E357-E365.
59. Coppack SW, Fisher RM, Persson M, Miles JM. Fatty acid release from adipose tissue relates to lipoprotein concentrations (Abstract). Eur Lipoprotein Club 1995; 18: 40.
60. Arner P, Bülow J. Assessment of adipose tissue metabolism in man: comparison of Fick and microdialysis techniques. Clin Sci 1993; 85: 247-256.
61. Arner P. Techniques for the measurement of white adipose tissue metabolism: a practical guide. Int J Obes Rel Metab Dis 1995; 19: 435-442.
62. Frayn KN, Coppack SW, Humphreys SM. Subcutaneous adipose tissue metabolism studied by local catheterisation. Int J Obes Rel Metab Dis 1993; 17 (suppl 3): S18-S21.
63. Coppack SW, Frayn KN, Humphreys SM, Dhar H, Hockaday TDR. Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci 1989; 77: 663-670.
64. Hodgetts V, Coppack SW, Frayn KN, Hockaday TDR. Factors controlling fat mobilisation from human subcutaneous adipose tissue during exercise. J Appl Physiol 1991; 71: 445-451.
65. Kurpad AV, Khan K, Calder G, et al. Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous abdominal adipose tissue in humans in vivo. Clin Sci 1994; 86: 177-184.
66. Björntorp P. Are regional metabolic differences of adipose tissue responsible for different risks of obesity? Horm Metab Res Suppl 1988; 19: 23-25.
67. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88-98.
68. Garn S, Sullivan TV, Hawthorne V. Evidence against functional differences between 'central' and 'peripheral' fat. Am J Clin Nutr 1988; 47: 836-839.
69. Coppack SW, Evans RD, Fisher RM, et al. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992; 41: 264-272.
70. Coppack SW, Fisher RM, Humphreys SM, Clark ML, Pointon JJ, Frayn KN. Carbohydrate metabolism in insulin resistance: glucose uptake and lactate production by adipose tissue and forearm tissues in vivo before and after a mixed meal. Clin Sci (in press).
71. Lewis GF, O'Meara NM, Soltys PA, et al. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 1990; 71: 1041-1050.
72. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989; 320: 1060-1068.
73. Cryer A. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem 1981; 13: 525-541.
74. Coppack SW, Fisher RM, Gibbons GF, et al. Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci 1990; 79: 339-348.
75. Potts JL, Fisher RM, Humphreys SM, Coppack SW, Gibbons GF, Frayn KN. Peripheral triacylglycerol extraction in the fasting and post-prandial states. Clin Sci 1991; 81: 621-626.
76. Lithell H, Boberg J, Hellsing K, et al. Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and fed states. Atherosclerosis 1978; 30: 89-94.
77. Eckel RH. Adipose tissue lipoprotein lipase. In: Borensztajn J, ed. Lipoprotein Lipase. Chicago: Evener Publishers, Inc., 1987: 79-132.
78. Tall AR, Small DM. Current concepts: plasma high-density lipoproteins. N Engl J Med 1978; 299: 1232-1236.
79. Fisher RM, Coppack SW, Kottke BA, Miles JM. Lipoprotein-lipase mediated effects on the composition of VLDL particles in vivo (Abstract). Atherosclerosis 1994; 109: S233.
80. Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF, Frayn KN. Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 1995; 268: E588-E594.
81. Frayn KN, Shadid S, Hamlani R, et al. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol 1994; 266: E308-E317.
82. Hollenbeck CB, Chen Y-DI, Greenfield MS, Lardinois CK, Reaven GM. Reduced plasma high density lipoproteincholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1986; 62: 605-608.
83. Capurso A. Drugs affecting triglycerides. Cardiology 1991; 78: 218-225.
84. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245-1255.
85. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary prevention trial with gemfibrizol in middle-aged men with dyslipidemia. N Engl J Med 1987; 317: 1237-1245.
86. Mann JI, Illingworth DR. Nutrition and therapeutics. Curr Opin Lipidol 1994; 5: 1-5.
87. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994; 344: 1719-1723.